title: Treatment-free remission after stopping second-line dasatinib.
authors.affiliation: Haematology Directorate, SA Pathology, Adelaide, SA, Australia; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia; Flinders University, Adelaide, SA 5000, Australia. Electronic address: david.ross@sa.gov.au.
authors.forename: David M
authors.initials: DM
authors.lastname: Ross
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000069439:Dasatinib; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D000069439:Dasatinib